Security Snapshot

PROSHARES TR - HGH YLD INT RATE (HYHG) Institutional Ownership

CUSIP: 74348A541

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

50

Shares (Excl. Options)

1,076,147

Price

$63.72

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-17,861
Value change
-$1,193,339
Number of holders
50
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$64.97
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • HYHG - PROSHARES TR - HGH YLD INT RATE is tracked under CUSIP 74348A541.
  • 50 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 47 to 50 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $71,172,283 to $68,589,126.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 50 institutions filings for Q1 2026.

Open SEC evidence

Security key

74348A541

Latest holder period

Q1 2026

13F holders

50

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 50 institutional investors reported holding 1,076,147 shares of PROSHARES TR - HGH YLD INT RATE (HYHG).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,076,147 $68,589,126 -$1,193,339 $63.72 50
2025 Q4 1,104,452 $71,172,283 -$3,236,073 $64.40 47
2025 Q3 1,064,988 $69,309,658 +$3,163,432 $65.14 43
2025 Q2 1,021,278 $66,179,399 -$16,376,433 $64.80 40
2025 Q1 1,256,343 $80,472,569 +$13,921,301 $64.05 41
2024 Q4 1,047,105 $68,669,160 +$13,465,636 $65.54 46
2024 Q3 840,309 $54,458,412 -$728,517 $64.80 36
2024 Q2 852,234 $54,655,553 -$7,530,122 $64.14 41
2024 Q1 973,878 $62,224,799 +$9,657,007 $63.92 40
2023 Q4 823,290 $51,780,795 +$1,684,771 $62.90 38
2023 Q3 783,451 $48,182,645 -$6,171,771 $61.52 38
2023 Q2 853,358 $54,096,923 -$1,394,937 $61.18 35
2023 Q1 899,176 $53,690,096 +$1,136,815 $59.72 34
2022 Q4 881,488 $51,502,053 -$1,068,939 $58.40 37
2022 Q3 901,319 $52,061,762 -$1,679,665 $57.74 37
2022 Q2 937,939 $53,299,293 -$5,107,573 $56.78 36
2022 Q1 1,030,124 $64,295,712 +$7,681,462 $62.42 31
2021 Q4 907,130 $56,922,954 +$2,882,762 $62.75 32
2021 Q3 857,239 $54,037,135 +$11,812,947 $63.04 26
2021 Q2 669,833 $42,310,009 +$11,781,700 $63.16 25
2021 Q1 483,316 $30,563,847 +$5,148,329 $63.24 24
2020 Q4 402,517 $24,995,454 -$5,173,408 $62.10 24
2020 Q3 486,220 $29,032,058 +$7,734,220 $59.70 28
2020 Q2 356,704 $20,734,066 -$23,604,175 $58.13 27
2020 Q1 762,728 $42,000,331 +$12,892,100 $55.07 25
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .